How have OMBP shares performed in 2024?

Omni Bio Pharmaceutical's stock was trading at $0.0010 at the beginning of the year. Since then, OMBP shares have increased by 0.0% and is now trading at $0.0010. View the best growth stocks for 2024 here .

What other stocks do shareholders of Omni Bio Pharmaceutical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Omni Bio Pharmaceutical investors own include Xenon Pharmaceuticals (XENE) , aTyr Pharma (LIFE) , 23895 (GKX.V) (GKX) , Flexion Therapeutics (FLXN) , Biocept (BIOC) and Acorda Therapeutics (ACOR) .

How do I buy shares of Omni Bio Pharmaceutical?

Shares of OMBP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:OMBP

Omni Bio Pharmaceutical (OMBP) Stock Price, News & Analysis

→ I’m officially sounding the alarm. (From Altimetry) (Ad)

Free OMBP Stock Alerts

$0.0010

0.00 (0.00%)

(As of 08/18/2020)

Compare

Today's Range: $0.0010
▼
$0.0010
50-Day Range: N/A
52-Week Range: $0.00
▼
$0.04

Volume: N/A
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Omni Bio Pharmaceutical alerts:

Ad Altimetry

I’m officially sounding the alarm.

AI has been the hottest financial story of 2023. And rightly so – AI stocks have beat the broader market by over 62%. But right now, my system is warning me that many AI stocks are riding higher on hype alone.

Just click here to watch my full uncensored interview.

About Omni Bio Pharmaceutical

Omni Bio Pharmaceutical, Inc. operates as a biopharmaceutical company in the United States. It holds a license to use patent for the treatment of diabetes using plasma-derived alpha-1 antitrypsin (p-AAT), a protein that is purified from human blood. The company also holds licenses for the use of patents and patent applications covering the use of p-AAT in the treatment of cellular transplantation and graft rejection, radiation protection, bacterial and viral diseases, myocardial remodeling, and inflammatory bowel disease indications. In addition, it holds licenses for patent applications covering compositions of various Fc-AAT constructs. Omni Bio Pharmaceutical, Inc. was founded in 2006 and is headquartered in Fort Collins, Colorado.

OMBP Stock Price History

30 days | 90 days | 365 days | Advanced Chart

OMBP Stock News Headlines

March 2, 2024 | morningstar.com

Zhejiang Wolwo Bio-Pharmaceutical Co Ltd Class A

December 2, 2023 | investing.com

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (1349)

April 19, 2024 | Altimetry (Ad)

I’m officially sounding the alarm.

November 12, 2023 | morningstar.com

Shanxi Jinbo Bio pharmaceutical Co Ltd 832982

October 6, 2023 | nasdaq.com

Oversold Conditions For BridgeBio Pharma (BBIO)

August 24, 2023 | morningstar.com

Sinopep Allsino Bio Pharmaceutical Co Ltd Class A

May 16, 2023 | wsj.com

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd.

April 22, 2023 | marketwatch.com

2023 Bio Pharma Logistics Market | Dynamic Report By 2030

April 19, 2024 | Altimetry (Ad)

I’m officially sounding the alarm.

April 21, 2023 | morningstar.com

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Class H

March 31, 2023 | marketwatch.com

Bio-pharma Market Key Players and Forecast till 2031

March 29, 2023 | marketwatch.com

2023 Bio Pharma Logistics Market Size, Growth | Global Industry Trends [2029]

March 25, 2023 | thestreet.com

My Five Favorite Bio-Pharma Stocks from the J.P. Morgan Healthcare Conference

March 22, 2023 | wsj.com

Zhejiang Wolwo Bio Pharmaceutical Co. Ltd.

February 22, 2023 | morningstar.com

Zhejiang Wolwo Bio-Pharmaceutical Co Ltd Class A 300357 Stock Quote

January 27, 2023 | marketwatch.com

Bio Pharma Logistics Market [Latest Report ]2023 is Booming with Figures, Sales Volume, Financial Barriers and Outlook to 2027

January 5, 2023 | forbes.com

BioMarin Pharmaceutical

October 7, 2022 | reuters.com

Zhejiang Wolwo Bio-Pharmaceutical Co Ltd

September 22, 2022 | investing.com

Sinopep Allsino Bio Pharmaceutical Co Ltd (688076)

July 8, 2022 | apnews.com

Slingshot Biosciences, Inc. Partners with OLS – OMNI Life Science to Distribute Synthetic Cells Throughout Germany, Austria, Switzerland, and Italy

See More Headlines

Receive OMBP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Omni Bio Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/19/2024
Fiscal Year End: 3/31/2025

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Biological products, except diagnostic
Sub-Industry: N/A
Current Symbol: OTCMKTS:OMBP
CUSIP: N/A
CIK: 1389870
Web: www.omnibiopharma.com
Phone: 970-237-5178
Fax: N/A
Employees: 1
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

Dr. Leland Shapiro M.D.
Principal Investigator for Viral & Bacterial Disorders

Key Competitors

View All Competitors

OMBP Stock Analysis - Frequently Asked Questions

How have OMBP shares performed in 2024?: Omni Bio Pharmaceutical's stock was trading at $0.0010 at the beginning of the year. Since then, OMBP shares have increased by 0.0% and is now trading at $0.0010.
View the best growth stocks for 2024 here.
What other stocks do shareholders of Omni Bio Pharmaceutical own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Omni Bio Pharmaceutical investors own include Xenon Pharmaceuticals (XENE), aTyr Pharma (LIFE), 23895 (GKX.V) (GKX), Flexion Therapeutics (FLXN), Biocept (BIOC) and Acorda Therapeutics (ACOR).
How do I buy shares of Omni Bio Pharmaceutical?: Shares of OMBP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:OMBP) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Omni Bio Pharmaceutical (OMBP) Stock Price, News & Analysis

About Omni Bio Pharmaceutical

OMBP Stock Price History

OMBP Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

OMBP Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info